Clinical Trials Sponsored by Dr. Liane S. Feldman
Total 1 results
-
Dr. Liane S. FeldmanSociety of American Gastrointestinal and Endoscopic SurgeonsCompletedColorectal DisordersCanada
Sponsors and Collaborators
- Department of Cardiology, Lausanne University Center Hospital, Lausanne, Switzerland
- Belfast Arthroplasty Research Trust (BART)
- Mexican Emerging Infectious Diseases Clinical Research Network
- Crowley Carter Foundation
- MB Clinical Research, LLC
- Fabian Rohner
- GTEI
- José Castro
- Biotics, Inc.
- University of Valladolid
- Narhalsan primary care rehabilitation
- Bon Secours Pediatric Dental Associates
- Don Cockcroft
- Hospital Sirio-Libanes Ensino e Pesquina
- Damagen Genetic Diagnostic Center
- Shanghai IxCell Biotechnology Co., LTD
- Castleton University
- Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)
- Junta de Andalucía - Consejería de Salud y Familias, Spain
- Universität Tübingen
- View Full List
Medical Conditions
- Shared Decision Making
- Vagus Nerve Injuries
- Disturbance of Attention
- Diabetic Kidney Disease (DKD)
- Genome-wide High Throughput Sequencing
- Opiate Dependent Patients Who Are Undergoing Inpatient Detoxification in Singapore
- Retention of 3D Printed Dentures
- Malignant Neoplasms of Female Genital Organs
- To Contribute to a Better Control of COVID-19 in Children in Niger
- Nerve Entrapments
- Multimodal Ultrasonographic Assessment of Axillary Lymph Nodes in Patients With Breast Cancer
- FLT3-ITD
- Bulging of Vaginal Wall
- Support Program
- Rejection Acute Hepatic
- Prostate Specific Antigens
- Unintentional Ingestion of Drugs Contained Within Prescription Vials and Blisters.
- Gastrointestinal Stromal Tumor of Stomach
- Confirmed Diagnosis of Cystic Fibrosis
- Tracheal Dilatation
- View Full List
Drug Interventions
- Etanercept
- Lidocaine, epinephrine (Local anesthetic)
- Gliadel Wafer
- Fluorouracil
- Cabozantinib
- PF-05212384
- Quadratus Lumborum Block type 2
- Metoprolol succinate sustained-release tablet
- Sulfasalazine
- Trimetazidine 35 mg
- Axitinib plus toripalimab
- ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
- Azacitidine
- Dapagliflozin
- PEP005 Gel
- ABT-199
- Granulocyte colony-stimulating factor (G-CSF)
- SNAC
- Fluorescein + ALA
- Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Austria
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Malawi
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Romania
- Contract Research Organizations in United States
- CRO list by country